NEW YORK (GenomeWeb) – Opko Health reported after the close of the market Monday that its third quarter revenues jumped 108 percent compared to Q3 2015, driven primarily by revenues from clinical lab BioReference Laboratories, which it acquired in August 2015.

For the three-month period ended Sept. 30, Opko's revenues rose to $298.0 million from $143.0 million a year ago, missing Wall Street analysts' consensus estimate for revenues of $322.0 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.